Showing 1131-1140 of 20391 results for "".
Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
https://reachmd.com/clinical-practice/cardiology/hypertrophic-cardiomyopathy-overcoming-practical-barriers-to-treatment-in-the-era-of-myosin-inhibitors/56414/Dive into practical barriers to myosin inhibitor use in HCM and learn strategies to support timely initiation and access for eligible patients.From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
https://reachmd.com/programs/cme/from-beta-blockers-to-myosin-inhibitors-initial-decision-making-in-obstructive-hcm/54843/Explore how cardiac myosin inhibitors are reshaping obstructive HCM management, from unmet needs to individualized, evidence-based treatment.Kappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/kappa-free-light-chain-index-in-the-diagnosis-of-multiple-sclerosis/54598/Adoption of the kappa free light chain index can enhance diagnostic accuracy and reduce latency in multiple sclerosis diagnosis, complementing MRI and expert assessment in clinical decision-making.Case Review: Can You Crack This IBD Case?
https://reachmd.com/programs/cme/case-review-can-you-crack-this-ibd-case/51484/Explore IBD from diagnosis to remission with practical cases, treatment strategies, and a treat-to-target approach for optimal patient outcomes.Introduction to Alloimmunization During Pregnancy
https://reachmd.com/programs/alloimmune-disorders-pregnancy/introduction-to-alloimmunization-during-pregnancy/13913/Can you successfully identify and treat your patients who may be at risk of alloimmune disorders of pregnancy?Pruritus In PN and AD: Challenge How You Manage Itch
https://reachmd.com/programs/cme/pruritus-in-pn-and-ad-challenge-how-you-manage-itch/36304/Use validated assessment tools to prioritize and measure itch in prurigo nodularis and atopic dermatitis in an interactive CME escape room.Comparing Trial Designs & Outcomes Across IGF-1R Therapies
https://reachmd.com/programs/cme/comparing-trial-designs-outcomes-across-igf-1r-therapies/60945/Explore how experts are rethinking TED severity and integrating modern therapies to personalize treatment and manage individual disease burden.Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
https://reachmd.com/programs/cme/understanding-igf-1r-inhibition-mechanism-clinical-implications/60944/Explore how experts are rethinking TED severity and integrating modern therapies to personalize treatment and manage individual disease burden.Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 1
https://reachmd.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-1/54619/In the first installment of this eight-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, discuss the rationale behind studying adjuvant skincare and the often-overlooked role of barrier repair in psoriasis management.1 Draelos Z, HougeiNSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
https://reachmd.com/programs/cme/nsclc-data-review-efficacy-and-safety-data-for-on-state-ras-inhibitors/54121/Explore ON-state RAS inhibitors for the treatment of NSCLC and pancreatic cancer, including mechanisms, efficacy data, and integration into clinical practice.